NCT00093964 2019-04-16
Cilengitide (EMD 121974) for Recurrent Glioblastoma Multiforme (Brain Tumor)
EMD Serono
Phase 2 Completed
Clinical Trials
6 trialsNCT00679354 2018-08-01
Cilengitide in Treating Younger Patients With Recurrent or Progressive High-Grade Glioma That Has Not Responded to Standard Therapy
National Cancer Institute (NCI)
Phase 2 Completed
NCT00813943 2017-01-30
CORE
EMD Serono
Phase 2 Completed
NCT00842712 2017-01-13
CERTO
Merck KGaA, Darmstadt, Germany
Phase 2 Completed
NCT00121238 2016-04-28
Cilengitide in Treating Patients With Prostate Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT00103337 2013-02-28
Cilengitide in Treating Patients With Metastatic Prostate Cancer
National Cancer Institute (NCI)
Phase 2 Completed